News

Multimedia

Conferences

Publications

Brand Insights

Resources

Sustainability
DE&I
Pandemic
Finance
Legal
Technology
Regulatory
Global
Pricing
Strategy
R&D/Clinical Trials
Opinion
Executive Roundtable
Sales & Marketing
Executive Profiles
Leadership
Market Access
Patient Engagement
Supply Chain
Industry Trends

BioMarin CEO Named as an EY Entrepreneur of the Year

November 16, 2015

Article

November 16, 2015.

Ernst & Young have named Jean-Jacques Bienaimé, CEO of BioMarin Pharmaceutical, as EY Entrepreneur Of The Year 2015 in the Life Sciences category.

The award recognizes entrepreneurs "who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities". Jean-Jacques Bienaimé was selected by an independent panel of judges and honored at the EY Entrepreneur Of The Year National Awards gala on November 14, 2015, in Palm Springs, California.

Related Content

AI in Pharma: Where, When, and How Executives are Considering it

Gaugarin Oliver

November 19th 2024

Article

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Mike Hollan

November 15th 2024

Article

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

The Leap Forward: Practical Gains for Pharma AI Use

Bianca Anghelina;Helen Merianos;Ruth Beadle

November 14th 2024

Article

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.